SHARE

News Alert: Citius Pharmaceuticals Receives FDA Approval For LYMPHIR™ (Denileukin Diftitox-Cxdl) Immunotherapy For The Treatment Of Adults With Relapsed Or Refractory Cutaneous T-Cell Lymphoma. Click to Read More.

Andy Carpenter belongs to the list of most influential names in the OTC stocks promotional industry. However, he also has his set of failures and Ecosciences Inc (OTCMKTS:ECEZ) is one of them. The promotional campaign of company started back in May with a book and the compensation revealed for the paid pump was $350,000.

The details

Mr. Carpenter’s introduced a colourful and optimistic landing page of Ecosciences with circulation of newsletters to support the campaign. The stock recorded a few high volume days and then moved back into a silent territory. The price target of $3.67 a share on ECEZ failed to impress investors and slowly interest faded away completely.

It is important to mention that the stock maintained its gains and traded close to $0.50 for entire May, and then it was in the second week of June, the stock recorded a sharp decline to trade around $0.40. It was still a decent decline as usually penny stock firms tend to destroy much more large portions of their gains after paid pumps.

The promotion

The third parties are still actively promoting Ecosciences stock. The landing page introduced by Mr. Carpenter is active and kicking. Also, the promotional newsletters are finding their way to investors’ email accounts. OTC Magic even informed that they have heard about a very big promotional campaign coming in near future.

This disclosure appears to be the reason behind reignited interest in Ecosciences stock. On July 9, 2015 the stock recorded its active session in a while and gained more than 22% to close the trading day at $0.441 per share. The gains continued in last trading session as stock price of Ecosciences Inc (OTCMKTS:ECEZ) gained more than 2% to close the trading session at $0.450. The gains came at a share volume of 407,504 compared to average share volume of 68,823.